BOS Manchester 2023 scope is primarily development stage CMC outsourcing for both Small Molecules and Biologics and also covering Novel Therapeutic Entities.
We have a single-track programme consisting of high-quality presentations and drawing from the diverse organisation types in the community including multinational pharmaceutical companies, speciality pharma, SME biotech, CRO/CMO and Consultants. Our programme consists of the following modules:
Outsourcing Business Process
Exploring strategies and processes driving sourcing and procurement of R&D services
Exploring the technical elements of outsourcing discovery R&D, Drug Substance Outsourcing, Analytical Development Outsourcing, Drug Product Outsourcing for Biologics and Small Molecules.
Outsourcing Case Studies
Building on the Technical Operations sessions, demonstrating outsourcing approaches to real life scenarios.
Trends in Pharmaceutical Outsourcing
Following our popular closing panel sessions at BOS Events 2022 we will be honing in on a specific topic that came to light and taking a deeper dive, stay tuned for further details.